Digital Microfluidics in Newborn Screening for Mucopolysaccharidoses: A Progress Report
Newborn screening (NBS) for mucopolysaccharidosis type I (MPS I, Hurler syndrome) is currently conducted in about two-fifths of the NBS programs in the United States and in a few other countries. Screening is performed by measurement of residual activity of the enzyme <i>alpha</i>-<sp...
Saved in:
Main Authors: | Jon Washburn (Author), David S. Millington (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Newborn screening in mucopolysaccharidoses
by: Maria Alice Donati, et al.
Published: (2018) -
Correction to: Newborn screening in mucopolysaccharidoses
by: Maria Alice Donati, et al.
Published: (2019) -
ENT and mucopolysaccharidoses
by: Pier Marco Bianchi, et al.
Published: (2018) -
Current and new therapies for mucopolysaccharidoses
by: Monica Penon-Portmann, et al.
Published: (2023) -
Orthopaedic challenges for mucopolysaccharidoses
by: Andrea Borgo, et al.
Published: (2018)